CRNX- Crinetics Pharmaceuticals, Inc.

Name: Crinetics Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Crinetics Pharmaceuticals, Inc. (CRNX) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Struthers Richard Scott	426.8K	$15.99M	-
Dir	Wierenga Wendall	116.1K	$4.35M	-
Other	Pizzuti Dana	71.8K	$2.69M	-
Other	Kalofonos Isabel	55.0K	$2.06M	-
COO	Knight Jeff E.	55.0K	$2.06M	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 8, 2023	Vivaldi Coelho Rogerio	Director	Buy	5,000	$22.06	$110,300.00	New	-24.5%	+103.6%
Apr 5, 2023	Pizzuti Dana56	Chief Development Officer	Sell	8,212	$16.15	$132,623.80	-64.6%	+12.9%	+192.5%
Feb 1, 2023	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$19.59	$61,238.34	-4.6%	+4.3%	+86.1%
Jan 25, 2023	Betz Stephen F.61	Chief Scientific Officer	Sell	8,336	$21.07	$175,639.52	-10.9%	-12.0%	+76.5%
Jan 17, 2023	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$18.00	$56,268.00	-3.9%	-10.9%	+92.6%
Jan 3, 2023	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$18.35	$57,362.10	-3.8%	-7.5%	+93.1%
Dec 15, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$16.00	$50,016.00	-3.7%	+5.8%	+112.2%
Dec 1, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$17.84	$55,767.84	-3.5%	+11.8%	+86.3%
Nov 15, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$18.72	$58,518.72	-3.4%	+9.9%	+58.3%
Nov 1, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$18.52	$57,893.52	-3.3%	+3.2%	+59.7%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC